Domenico Liguoro | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors	CELL DEATH & DISEASE	2024
ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation	BIOMEDICINES	2023
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2023
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance	ONCOGENE	2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications	CANCERS	2022
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma	THERANOSTICS	2022
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications	CANCERS	2022
The promise of liquid biopsy to predict response to immunotherapy in metastatic melanoma	FRONTIERS IN ONCOLOGY	2021
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting	CANCER LETTERS	2021
In vitro biophysical and biological characterization of lipid nanoparticles Co-encapsulating oncosuppressors miR-199b-5p and miR-204-5p as potentiators of target therapy in metastatic melanoma	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020
Drug tolerance to target therapy in melanoma revealed at single cell level: What next?	BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER	2020
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin	CANCERS	2019
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma	CELL DEATH & DISEASE	2019
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma	CELL DEATH AND DIFFERENTIATION	2018